| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aurora Kinase A | 3 | 2024 | 210 | 0.800 |
Why?
|
| Neoplastic Stem Cells | 5 | 2013 | 1457 | 0.690 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2018 | 26 | 0.630 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2018 | 72 | 0.620 |
Why?
|
| Aurora Kinase B | 1 | 2015 | 67 | 0.510 |
Why?
|
| Triple Negative Breast Neoplasms | 3 | 2015 | 1388 | 0.500 |
Why?
|
| Breast Neoplasms | 11 | 2024 | 16182 | 0.500 |
Why?
|
| Cell Communication | 1 | 2017 | 512 | 0.490 |
Why?
|
| Indazoles | 1 | 2015 | 310 | 0.450 |
Why?
|
| Integrin alpha6 | 1 | 2013 | 18 | 0.440 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2018 | 1002 | 0.410 |
Why?
|
| Neovascularization, Pathologic | 1 | 2017 | 1585 | 0.360 |
Why?
|
| HCT116 Cells | 2 | 2011 | 354 | 0.340 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2013 | 551 | 0.330 |
Why?
|
| Piperazines | 2 | 2015 | 2145 | 0.330 |
Why?
|
| Mammary Neoplasms, Animal | 2 | 2024 | 236 | 0.320 |
Why?
|
| Neoplasm Metastasis | 2 | 2017 | 5309 | 0.300 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2008 | 257 | 0.290 |
Why?
|
| Loss of Heterozygosity | 1 | 2008 | 622 | 0.270 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2006 | 110 | 0.270 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2017 | 5403 | 0.260 |
Why?
|
| MicroRNAs | 1 | 2017 | 2886 | 0.240 |
Why?
|
| Homeodomain Proteins | 2 | 2011 | 1124 | 0.230 |
Why?
|
| Inflammatory Breast Neoplasms | 3 | 2014 | 530 | 0.230 |
Why?
|
| Peptide Elongation Factor 1 | 1 | 2024 | 26 | 0.230 |
Why?
|
| SOXC Transcription Factors | 1 | 2024 | 58 | 0.230 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2013 | 2453 | 0.230 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2024 | 10382 | 0.230 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 4 | 2013 | 506 | 0.210 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2006 | 841 | 0.190 |
Why?
|
| Hyaluronan Receptors | 3 | 2011 | 248 | 0.190 |
Why?
|
| Biomarkers, Tumor | 5 | 2024 | 10699 | 0.180 |
Why?
|
| Spheroids, Cellular | 2 | 2012 | 217 | 0.180 |
Why?
|
| Interleukin-15 | 1 | 2021 | 189 | 0.170 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2015 | 4960 | 0.170 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2024 | 690 | 0.160 |
Why?
|
| Lymphatic Metastasis | 1 | 2008 | 4957 | 0.160 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2024 | 1012 | 0.160 |
Why?
|
| Picolinic Acids | 1 | 2018 | 16 | 0.160 |
Why?
|
| Benzothiazoles | 1 | 2018 | 102 | 0.150 |
Why?
|
| Vimentin | 1 | 2018 | 255 | 0.140 |
Why?
|
| Carcinoma | 1 | 2008 | 2609 | 0.140 |
Why?
|
| MCF-7 Cells | 1 | 2018 | 547 | 0.140 |
Why?
|
| Epigenesis, Genetic | 1 | 2024 | 1442 | 0.140 |
Why?
|
| Cell Proliferation | 4 | 2015 | 7234 | 0.140 |
Why?
|
| Rituximab | 1 | 2021 | 1590 | 0.130 |
Why?
|
| Mice | 10 | 2024 | 35574 | 0.130 |
Why?
|
| Cadherins | 1 | 2018 | 657 | 0.120 |
Why?
|
| Exosomes | 1 | 2017 | 255 | 0.120 |
Why?
|
| Tumor Suppressor Protein p14ARF | 2 | 2011 | 101 | 0.120 |
Why?
|
| Disease Progression | 2 | 2024 | 6851 | 0.120 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2006 | 3656 | 0.120 |
Why?
|
| Female | 17 | 2024 | 148723 | 0.110 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2012 | 39 | 0.100 |
Why?
|
| Benzimidazoles | 1 | 2015 | 437 | 0.100 |
Why?
|
| Humans | 22 | 2024 | 270462 | 0.100 |
Why?
|
| Animals | 10 | 2024 | 62012 | 0.100 |
Why?
|
| Stomach Neoplasms | 3 | 2011 | 2324 | 0.100 |
Why?
|
| Cell Line, Tumor | 6 | 2024 | 14825 | 0.100 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2015 | 16640 | 0.100 |
Why?
|
| Neoplasms | 1 | 2017 | 15900 | 0.090 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2011 | 32 | 0.090 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2008 | 1229 | 0.090 |
Why?
|
| Cell Separation | 1 | 2012 | 610 | 0.090 |
Why?
|
| Mice, Knockout | 4 | 2013 | 5725 | 0.090 |
Why?
|
| Cell Line | 1 | 2018 | 5339 | 0.090 |
Why?
|
| Genes, myc | 1 | 2011 | 372 | 0.090 |
Why?
|
| Protein Isoforms | 2 | 2011 | 848 | 0.090 |
Why?
|
| Wnt1 Protein | 1 | 2009 | 100 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 539 | 0.080 |
Why?
|
| Hematologic Neoplasms | 1 | 2021 | 1948 | 0.080 |
Why?
|
| AC133 Antigen | 1 | 2009 | 107 | 0.080 |
Why?
|
| Flow Cytometry | 2 | 2013 | 3044 | 0.080 |
Why?
|
| Cohort Studies | 4 | 2013 | 9470 | 0.080 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2015 | 3911 | 0.080 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 1199 | 0.080 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2013 | 1401 | 0.080 |
Why?
|
| Dinoprostone | 1 | 2009 | 219 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 1 | 2021 | 4479 | 0.080 |
Why?
|
| Bone Neoplasms | 2 | 2014 | 2663 | 0.080 |
Why?
|
| Epirubicin | 1 | 2008 | 159 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 2474 | 0.070 |
Why?
|
| Quantitative Trait Loci | 1 | 2008 | 384 | 0.070 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2011 | 513 | 0.070 |
Why?
|
| Microsatellite Repeats | 1 | 2008 | 628 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2024 | 9036 | 0.070 |
Why?
|
| Apoptosis | 3 | 2015 | 7752 | 0.060 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2013 | 823 | 0.060 |
Why?
|
| Glycoproteins | 1 | 2009 | 779 | 0.060 |
Why?
|
| Breast Diseases | 1 | 2007 | 200 | 0.060 |
Why?
|
| Imidazoles | 1 | 2011 | 1057 | 0.060 |
Why?
|
| Mice, SCID | 1 | 2009 | 1825 | 0.060 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2007 | 396 | 0.060 |
Why?
|
| Axilla | 1 | 2008 | 933 | 0.060 |
Why?
|
| Cytarabine | 1 | 2011 | 2013 | 0.060 |
Why?
|
| Immunoenzyme Techniques | 1 | 2006 | 1189 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 2 | 2013 | 7096 | 0.060 |
Why?
|
| Taxoids | 1 | 2008 | 1015 | 0.060 |
Why?
|
| Antigens, CD | 1 | 2009 | 1419 | 0.060 |
Why?
|
| Carcinoma, Lobular | 1 | 2008 | 616 | 0.060 |
Why?
|
| F-Box-WD Repeat-Containing Protein 7 | 1 | 2024 | 80 | 0.060 |
Why?
|
| Neoplasm Proteins | 2 | 2016 | 3344 | 0.060 |
Why?
|
| Immunohistochemistry | 2 | 2013 | 7663 | 0.060 |
Why?
|
| Cell Movement | 1 | 2011 | 2471 | 0.060 |
Why?
|
| Receptors, Estrogen | 2 | 2011 | 2159 | 0.060 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2024 | 158 | 0.060 |
Why?
|
| Peptides | 1 | 2009 | 1504 | 0.060 |
Why?
|
| Antineoplastic Agents | 2 | 2021 | 14614 | 0.050 |
Why?
|
| Treatment Failure | 1 | 2006 | 1428 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 3 | 2024 | 4044 | 0.050 |
Why?
|
| Mutation, Missense | 1 | 2008 | 1193 | 0.050 |
Why?
|
| Middle Aged | 8 | 2014 | 90192 | 0.050 |
Why?
|
| Adult | 7 | 2014 | 81851 | 0.050 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2024 | 263 | 0.050 |
Why?
|
| Chemoembolization, Therapeutic | 1 | 2003 | 192 | 0.050 |
Why?
|
| Portal Vein | 1 | 2003 | 363 | 0.050 |
Why?
|
| Receptors, Progesterone | 1 | 2006 | 1603 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2008 | 4326 | 0.050 |
Why?
|
| Glioblastoma | 1 | 2011 | 1773 | 0.050 |
Why?
|
| Phenotype | 2 | 2009 | 6503 | 0.050 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2003 | 2173 | 0.050 |
Why?
|
| Aged | 7 | 2014 | 73248 | 0.040 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2006 | 914 | 0.040 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2003 | 637 | 0.040 |
Why?
|
| Catheter Ablation | 1 | 2003 | 574 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2008 | 6397 | 0.040 |
Why?
|
| Survival Analysis | 3 | 2014 | 9290 | 0.040 |
Why?
|
| Embolization, Therapeutic | 1 | 2003 | 605 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 2016 | 7909 | 0.040 |
Why?
|
| Prognosis | 3 | 2014 | 22466 | 0.040 |
Why?
|
| Thrombosis | 1 | 2003 | 743 | 0.040 |
Why?
|
| Polyethylene Glycols | 1 | 2021 | 654 | 0.040 |
Why?
|
| Aged, 80 and over | 3 | 2014 | 30976 | 0.030 |
Why?
|
| Liver Neoplasms | 2 | 2003 | 4815 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2008 | 10258 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2021 | 2344 | 0.030 |
Why?
|
| Neoadjuvant Therapy | 1 | 2008 | 5225 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2011 | 4955 | 0.030 |
Why?
|
| Epithelium | 1 | 2016 | 781 | 0.030 |
Why?
|
| Receptor, ErbB-2 | 1 | 2024 | 2650 | 0.030 |
Why?
|
| Survival Rate | 1 | 2006 | 12509 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2014 | 39760 | 0.030 |
Why?
|
| Time Factors | 1 | 2006 | 12996 | 0.030 |
Why?
|
| Mammary Glands, Animal | 1 | 2016 | 620 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2011 | 4223 | 0.030 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2011 | 34 | 0.020 |
Why?
|
| CD24 Antigen | 1 | 2011 | 88 | 0.020 |
Why?
|
| Nanog Homeobox Protein | 1 | 2011 | 63 | 0.020 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2011 | 105 | 0.020 |
Why?
|
| Smad3 Protein | 1 | 2011 | 123 | 0.020 |
Why?
|
| HT29 Cells | 1 | 2011 | 155 | 0.020 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2011 | 119 | 0.020 |
Why?
|
| Retinoblastoma Protein | 1 | 2011 | 339 | 0.020 |
Why?
|
| Prostaglandin-E Synthases | 1 | 2009 | 30 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2011 | 279 | 0.020 |
Why?
|
| Protein Stability | 1 | 2011 | 377 | 0.020 |
Why?
|
| Neural Stem Cells | 1 | 2011 | 182 | 0.020 |
Why?
|
| Necrosis | 1 | 2011 | 595 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2009 | 239 | 0.020 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2009 | 87 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2011 | 704 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2011 | 1554 | 0.020 |
Why?
|
| Receptors, Androgen | 1 | 2013 | 853 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2009 | 495 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2011 | 968 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2011 | 1462 | 0.020 |
Why?
|
| RNA Interference | 1 | 2011 | 1386 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2011 | 1757 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 3586 | 0.020 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2011 | 1347 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2011 | 2033 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2011 | 1366 | 0.020 |
Why?
|
| Paclitaxel | 1 | 2011 | 2100 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2011 | 4329 | 0.010 |
Why?
|
| Injections, Intralesional | 1 | 2003 | 166 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2011 | 4945 | 0.010 |
Why?
|
| Pregnancy | 1 | 2016 | 8110 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2011 | 5694 | 0.010 |
Why?
|
| Diaphragm | 1 | 2003 | 187 | 0.010 |
Why?
|
| Ethanol | 1 | 2003 | 271 | 0.010 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2003 | 332 | 0.010 |
Why?
|
| Rats | 1 | 2009 | 6524 | 0.010 |
Why?
|
| Gastrectomy | 1 | 2003 | 476 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 5141 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 7382 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2007 | 6253 | 0.010 |
Why?
|
| Hepatectomy | 1 | 2003 | 1012 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 22178 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2003 | 9039 | 0.010 |
Why?
|
| Male | 2 | 2011 | 128209 | 0.000 |
Why?
|